胃肠道肿瘤免疫治疗:当前认识
Immunotherapy in Gastrointestinal Cancers: Current Insights.
例如,过继性T细胞疗法,如靶向claudin18.2的CAR-T,在晚期胃癌和胃食管结合部癌患者中已达到48.6%的客观缓解率。
38.4分
★★☆☆☆
ALL SOURCES
Immunotherapy in Gastrointestinal Cancers: Current Insights.
例如,过继性T细胞疗法,如靶向claudin18.2的CAR-T,在晚期胃癌和胃食管结合部癌患者中已达到48.6%的客观缓解率。
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。